No Data
No Data
Pluri Inc | 10-Q: Q1 2025 Earnings Report
Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event
Brainstorm Cell Therapeutics and Pluri Shares Are Trading Higher After the Companies Entered Into a Memorandum of Understanding to Manufacture NurOwn for a Phase 3b Trial in Amyotrophic Lateral Sclerosis.
BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn Phase 3b Trial Manufacturing
Pluri Secures Israel Funding for MAIT Cell Cancer Therapy, Teams Up With Bar-Ilan University to Target Solid Tumors
Pluri Inc | 10-K: FY2024 Annual Report
No Data
No Data